Assignee
WISTAR INST
US·179 granted patents·129 pending applications·5,840 citations·filing 1974–2025
Top patents by PatentIndex Score
308 records- 0199US5593972AGenetic immunizationWISTAR INST·Filed 1993·Granted Jan 14, 1997·807 cites·9 claims
- 0299US4172124AMethod of producing tumor antibodiesWISTAR INST·Filed 1978·Granted Oct 23, 1979·273 cites·16 claims
- 0398US4196265AMethod of producing antibodiesWISTAR INST·Filed 1978·Granted Apr 1, 1980·841 cites·18 claims
- 0496US9402888B2Methods and compositions for treating cancerWISTAR INST·Filed 2014·Granted Aug 2, 2016·29 cites·9 claims
- 0596US5015568ADiagnostic methods for detecting lymphomas in humansWISTAR INST·Filed 1986·Granted May 14, 1991·141 cites·14 claims
- 0695US4471057ADetection of colorectal carcinomaWISTAR INST·Filed 1981·Granted Sep 11, 1984·103 cites·8 claims
- 0794US5571515ACompositions and methods for use of IL-12 as an adjuvantWISTAR INST·Filed 1994·Granted Nov 5, 1996·108 cites·3 claims
- 0894US5459251ADNA molecules having human bcl-2 gene sequencesWISTAR INST·Filed 1994·Granted Oct 17, 1995·98 cites·5 claims
- 0993US9868951B2Methods and compositions for enhancing the therapeutic effect of anti-tumor T cellsWISTAR INST·Filed 2015·Granted Jan 16, 2018·11 cites·20 claims
- 1093US5202429ADNA molecules having human BCL-2 gene sequencesWISTAR INST·Filed 1991·Granted Apr 13, 1993·124 cites·7 claims
- 1193US4849509AMonoclonal antibodies against melanoma-associated antigens and hybrid cell lines producing these antibodiesWISTAR INST·Filed 1987·Granted Jul 18, 1989·90 cites·5 claims
- 1292US11242317B2EBNA1 inhibitors and their method of useWISTAR INST·Filed 2019·Granted Feb 8, 2022·4 cites·17 claims
- 1392US9226936B2Methods and compositions for enhancing the therapeutic effect of anti-tumor T cellsWISTAR INST·Filed 2012·Granted Jan 5, 2016·13 cites·14 claims
- 1492US6019978AReplication-defective adenovirus human type 5 recombinant as a vaccine carrierWISTAR INST·Filed 1996·Granted Feb 1, 2000·125 cites·6 claims
- 1591US10981867B2EBNA1 inhibitors and methods using sameWISTAR INST·Filed 2019·Granted Apr 20, 2021·3 cites·13 claims
- 1691US10442763B2EBNA1 inhibitors and methods using sameWISTAR INST·Filed 2016·Granted Oct 15, 2019·4 cites·5 claims
- 1791US5591439ARecombinant cytomegalovirus vaccineWISTAR INST·Filed 1995·Granted Jan 7, 1997·145 cites·11 claims
- 1891US5582996ABifunctional antibodies and method of preparing sameWISTAR INST·Filed 1994·Granted Dec 10, 1996·310 cites·11 claims
- 1990US11207402B2Constructs for enhancing immune responsesWISTAR INST·Filed 2019·Granted Dec 28, 2021·3 cites·9 claims
- 2090US5714316AChimeric envelope proteins for viral targetingWISTAR INST·Filed 1993·Granted Feb 3, 1998·99 cites·11 claims
- 2190US4349528AMonocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigenWISTAR INST·Filed 1979·Granted Sep 14, 1982·50 cites·4 claims
- 2289US9724406B2Constructs for enhancing immune responsesWISTAR INST·Filed 2015·Granted Aug 8, 2017·8 cites·13 claims
- 2389US6852706B1Methods and compositions for healing heart woundsWISTAR INST·Filed 2001·Granted Feb 8, 2005·36 cites·11 claims
- 2489US6638408B1Method and device for separation of charged molecules by solution isoelectric focusingWISTAR INST·Filed 2000·Granted Oct 28, 2003·52 cites·33 claims
- 2589US5595869ADiagnostic methods for detecting lymphomas in humansWISTAR INST·Filed 1992·Granted Jan 21, 1997·56 cites·2 claims
- 2688US5523393ABCL-2 proteinsWISTAR INST·Filed 1995·Granted Jun 4, 1996·63 cites·3 claims
- 2788US5470571AMethod of treating human EGF receptor-expressing gliomas using radiolabeled EGF receptor-specific MAB 425WISTAR INST·Filed 1990·Granted Nov 28, 1995·86 cites·1 claims
- 2888US4693975AHuman hybridroma fusion partner for production of human monoclonal antibodiesWISTAR INST·Filed 1984·Granted Sep 15, 1987·64 cites·12 claims
- 2988US4608337AHuman hybridomas and the production of human monoclonal antibodies by human hybridomasWISTAR INST·Filed 1983·Granted Aug 26, 1986·55 cites·20 claims
- 3087US11208478B2Methods of detecting and treating a tumor expressing pT346 PDK1WISTAR INST·Filed 2017·Granted Dec 28, 2021·2 cites·8 claims
- 3187US5698202AReplication-defective adenovirus human type 5 recombinant as a rabies vaccine carrierWISTAR INST·Filed 1995·Granted Dec 16, 1997·92 cites·11 claims
- 3287US2026000753A1Constructs for enhancing immune responsesWISTAR INST·Filed 2025·Application pending·0 cites
- 3386US5506344AAntibodies specific for BCL-2 gene productWISTAR INST·Filed 1995·Granted Apr 9, 1996·54 cites·4 claims
- 3485US11382886B2Methods and compositions for treating cancerWISTAR INST·Filed 2017·Granted Jul 12, 2022·2 cites·18 claims
- 3585US10328146B2Contructs for enhancing immune responsesWISTAR INST·Filed 2017·Granted Jun 25, 2019·4 cites·22 claims
- 3685US9983215B2Methods and compositions for diagnosis of ectopic pregnancyWISTAR INST·Filed 2016·Granted May 29, 2018·3 cites·6 claims
- 3785US4971792AMonoclonal antibodies against glycolipid antigensWISTAR INST·Filed 1987·Granted Nov 20, 1990·68 cites·12 claims
- 3885US3959466AHighly attenuated cytomegalovirus vaccine and production thereofWISTAR INST·Filed 1974·Granted May 25, 1976·26 cites·8 claims
- 3984US2024246909A1EBNA1 Inhibitors and Methods Using SameWISTAR INST·Filed 2024·Application pending·0 cites
- 4084US2024342199A1Combination therapies targeting mitochondria for cancer therapyWISTAR INST·Filed 2024·Application pending·0 cites
- 4183US4108983AViral oncolysate vaccine for stimulating the immune mechanism of mammals to species-specific tumorsWISTAR INST·Filed 1976·Granted Aug 22, 1978·62 cites·17 claims
- 4282US12404307B2Methods and compositions for use of recombinant bacterial effector proteins as anti-inflammatory agentsWISTAR INST·Filed 2022·Granted Sep 2, 2025·1 cites·12 claims
- 4382US7514219B2Method for distinguishing between head and neck squamous cell carcinoma and lung squamous cell carcinomaWISTAR INST·Filed 2006·Granted Apr 7, 2009·4 cites·4 claims
- 4482US6831063B1Bridging Integrator-2(Bin2) nucleic acid molecules and proteins and uses thereforWISTAR INST·Filed 2000·Granted Dec 14, 2004·11 cites·5 claims
- 4582US6375944B1Methods and compositions for enhancing the immunostimulatory effect of interleukin-12WISTAR INST·Filed 1999·Granted Apr 23, 2002·55 cites·18 claims
- 4682US5246921AMethod for treating leukemiasWISTAR INST·Filed 1992·Granted Sep 21, 1993·130 cites·16 claims
- 4782US4701409ADetection of B-cell neoplasmsWISTAR INST·Filed 1984·Granted Oct 20, 1987·46 cites·7 claims
- 4882US2024207202A1Combination therapies targeting mitochondrial biogenesis for cancer therapyWISTAR INST·Filed 2023·Application pending·0 cites
- 4981US11230592B2DNA antibody constructs for use against middle east respiratory syndrome coronavirusWISTAR INST·Filed 2018·Granted Jan 25, 2022·2 cites·8 claims
- 5081US7354589B2Multiple antigenic agents and methods for using the sameWISTAR INST·Filed 2005·Granted Apr 8, 2008·2 cites·5 claims
Showing the top 50 of 308 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when WISTAR INST files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →